A senior citizen receives a Covid shot at a Beijing mobile vaccination site in April
China's government has demonstrated it's willing to go to extremes in its quest to contain the virus. But one thing it has so far been unwilling to do is deploy a powerful tool against the highly contagious omicron variant: mRNA vaccines. These shots could reduce the chances of elderly and other vulnerable Chinese getting seriously ill or dying and possibly help the country transition out of Covid Zero.
Lining up the necessary supplies shouldn't be a problem. Toward the end of 2020, Shanghai Fosun Pharmaceutical Group Co. reached a deal with Germany's BioNTech SE to distribute 100 million doses of the mRNA vaccine the German company co-developed with Pfizer Inc., once China's drug regulator gave the green light. Approval is still pending, though. Worldwide data clearly indicates mRNA is the gold standard, says Joerg Wuttke, president of the European Union Chamber of Commerce in China, which wrote to the Chinese government in April urging it to allow the shots. Why waste time and wait? For what?
The wait, many analysts say, is for a local company to come up with its own mRNA vaccine. Since the start of the pandemic, China's government has touted self-reliance in fighting Covid, promoting domestic vaccines based on inactivated versions of the virus and barring all foreign ones from the market. Slightly more than 88% of China's 1.4 billion people have received two doses of those shots. Opening up to foreign-made mRNA vaccines risks embarrassing President Xi Jinping and other officials, says Allison Hills, senior consultant in London with Eradigm Consulting. For them to say now we are accepting BioNTech, she says, it's tantamount to saying ours are not as good.
Esta historia es de la edición May 02, 2022 de Bloomberg Businessweek.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición May 02, 2022 de Bloomberg Businessweek.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Instagram's Founders Say It's Time for a New Social App
The rise of AI and the fall of Twitter could create opportunities for upstarts
Running in Circles
A subscription running shoe program aims to fight footwear waste
What I Learned Working at a Hawaiien Mega-Resort
Nine wild secrets from the staff at Turtle Bay, who have to manage everyone from haughty honeymooners to go-go-dancing golfers.
How Noma Will Blossom In Kyoto
The best restaurant in the world just began its second pop-up in Japan. Here's what's cooking
The Last-Mover Problem
A startup called Sennder is trying to bring an extremely tech-resistant industry into the age of apps
Tick Tock, TikTok
The US thinks the Chinese-owned social media app is a major national security risk. TikTok is running out of ways to avoid a ban
Cleaner Clothing Dye, Made From Bacteria
A UK company produces colors with less water than conventional methods and no toxic chemicals
Pumping Heat in Hamburg
The German port city plans to store hot water underground and bring it up to heat homes in the winter
Sustainability: Calamari's Climate Edge
Squid's ability to flourish in warmer waters makes it fitting for a diet for the changing environment
New Money, New Problems
In Naples, an influx of wealthy is displacing out-of-towners lower-income workers